Five things for pharma marketers to know: Tuesday, October 3, 2023

Five things for pharma marketers to know:

• The Supreme Court declined to hear a lawsuit by CareDx over organ-rejection tests made by Natera and Eurofins Viracor, turning down another request to revisit the contentious issue of patent eligibility.

• Cooler Screens sued Walgreens, claiming the pharmacy chain obstructed an agreed-upon nationwide rollout of the internet-connected doors and demanded their removal from stores.

• Genetic test developer Invitae said the Food and Drug Administration greenlit its Invitae Common Hereditary Cancers Panel, a first-of-its-kind test to identify cancer-related genes.

• After a large study failed in January, there is only one late-stage HIV vaccine trial ongoing and it uses older vaccine designs that some experts doubt will do much.

• Syros Pharmaceuticals announced it will cut 35% of its staff as the biopharmaceutical company tightens its focus on key drug candidate tamibarotene.